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ABSTRACT A human T-cell line constitutively expressing
the nef gene from the human immunodeficiency virus type 1
SF2 isolate was used to examie the distribution of the Nef
protein in the nucleus. High-resolution immunogold label-
ing/electron microscopic studies with polydonal anti-Nef an-
tibodies on nef+ and nef- cells revealed that a small fraction
of Nef is in the nucleus and it is localized in specific curvilinear
tracks that extend between the nuclear envelope and the
nucleoplasm. An examination of the sequence of the SF2 nef
gene revealed a putative nuclear targeting sequence that was
previously found in several other eukaryotic nucleoplasmic
proteins. The nuclear localization of Nef suggests a potential
nuclear function for this protein. The presence ofNefin distinct
nuclear tracks suggests that Nef is transported along a specific
pathway that extends from the nuclear envelope into the
nucleoplasm. A previous study [Meier, U. T. & Blobel, G.
(1992) Cell 70, 127-138] has shown that the nucleolar protein
of rat liver cells (Noppl40) shutties from the nucleolus to the
nuclear envelope on distinct tracks. The present study has
suggested that the transport of a nucleoplasmic protein may
also occur on distinct nuclear pathways.
The human immunodeficiency virus (HIV) is a complex
retrovirus that contains several genes that regulate virus
replication and gene expression (1-3). The role ofone ofthese
genes, nef, has been the subject ofa great deal of controversy
(4). Nef is encoded by a single open reading frame that
overlaps with the 3' long terminal repeat of HIV and simian
immunodeficiency virus (SIV) (4-6). Nef is a 27- to 32-kDa
protein that is myristoylated at its amino terminus (7-9). In
some instances, a 25-kDa product that is not myristoylated
has been reported; however, this form of Nef is not always
detectable (10). nefmRNA is detected along with that coding
for tat and rev early after infection (11). The presence of
antibodies reactive with Nef in patients infected with HIV or
in macaques infected with SIV is evidence of nefexpression
in vivo (12-15). Although Nef is not required for replication
in vitro, it is present in HIV-1, HIV-2, and SIV (4). The
conservation of this gene in all three viruses can be consid-
ered an indication that nef might have an effect on virus
replication or disease progression. Indeed, experiments con-
ducted using SIV (mac239 isolate) indicate that nefplays an
important role in the development of disease in vivo (16).
A knowledge of the subcellular distribution of Nef may
provide clues to its function. Previous light microscopic
studies using immunofluorescence or immunoperoxidase
techniques have found Nef primarily in the cytoplasm (7,
17-19) associated with the plasma membrane, Golgi complex,
and endoplasmic reticulum. A recent biochemical study has
demonstrated that a substantial fraction of Nef of HIV-1
associates with the cytoskeletal fraction of T lymphocytes
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and that the association is enhanced by myristoylation ofNef
(20). The distribution of Nef in the nucleus remains contro-
versial. Some recent studies using immunocytochemical
techniques at the light microscopic level have described the
possible association ofNef with the nuclear envelope and the
nucleoplasm (18, 19, 21). In this study we have attempted to
resolve the question of the nuclear localization of Nef in
human T cells using the high-resolution method of immu-
nogold/electron microscopy. The studies done with a highly
specific polyclonal antiserum to Nef have revealed that a
fraction of Nef is localized in distinct tracks in the nucleus.
MATERIALS AND METHODS
Cells and Antibodies. HPBALL human CD4+ T cells ex-
pressing nef (HPBALL/LnefSN-S1) or transduced with a
control vector (HPBALL/LN) have been described (22).
Cells were grown in RPMI medium containing 25 mM Hepes
and supplemented with 10% fetal bovine serum, penicillin,
and streptomycin. A rabbit anti-Nef polyclonal antiserum
(23) whose specificity was established by Western blot anal-
ysis (see Fig. 1) was used in immunogold labeling studies.
Monoclonal anti-vimentin (no. 814318) and anti-actin (no.
1378996) antibodies were obtained from Boehringer Mann-
heim. Monoclonal anti-tubulin (no. MABO65) antibodies
were purchased from Chemicon. The specificity of three
antibodies was established by immunofluorescence and/or
Western blot analysis.
Western Blot Analysis. To determine the specificity of the
rabbit anti-Nef polyclonal antiserum, HPBALL/LnefSN or
LN cells were lysed in 1% Nonidet P-40 buffer and proteins
were separated by SDS/PAGE on a 12.5% gel. Proteins were
transferred to a nitrocellulose fllter, probed with the anti-Nef
antiserum (1:500 dilution), and developed with goat anti-
rabbit alkaline phosphatase secondary antibody essentially
as described (24).
Immunofluorescence and Immunogold Labeling. Immuno-
fluorescence was performed as described (25). Briefly, cells
were spun (Cytospin) onto glass slides, fixed with 3.7%
paraformaldehyde, and permeabilized with acetone. Cells
were then incubated with the primary antibodies [diluted 10-
to 20-fold with phosphate-buffered saline (PBS)] at 37°C for
1 hr. After thorough rinsing, cells were incubated as above
with fluorescein-conjugated goat anti-rabbit antibodies (ICN;
diluted 10-fold with PBS). The slides were viewed and
photographed in a Zeiss IM35 microscope.
Immunogold labeling was done as described (26, 27) with
slight modifications. Cells were fixed in 2.0% paraformalde-
hyde/0.05% glutaraldehyde in 0.01 M sodium cacodylate
buffer, dehydrated in 15%, 30%, and 50% ethanol for 15 min
each, and stained with 2% uranyl acetate in 50% ethanol for
30 min. They were further dehydrated in 70% and 100%
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ethanol for 15 min each and immersed in 1:1 ethanol/LR
White resin (Polyscience) for 1 hr. Finally, they were em-
bedded in LR White resin for 24 hr at 50°C. Sections were cut
with a diamond knife on a Sorvall MT 6000 ultramicrotome
and picked up on nickel grids. For antibody labeling, grids
bearing sections were floated on drops of primary antibodies
(anti-Nef or anti-cytoskeleton) diluted 10- to 20-fold in Tris-
buffered saline (TBS, 500 mM NaCl/25 mM Tris, pH 7.6)
containing 0.1% fish gelatin and 0.5% bovine serum albumin.
Incubation was carried out at 10°C for 16 hr. Grids were
rinsed with TBS and floated on gold-conjugated second
antibodies (Amersham) diluted 20-fold with TBS containing
fish gelatin and bovine serum albumin. Incubation with the
gold-conjugated antibody was carried out at 21°C for 3 hr.
After thorough rinsing, grids were stained with Reynold's
lead citrate before electron microscopic examination. All
samples were examined in a Philips EM301 electron micro-
scope operated at 80 kV.
RESULTS
Nef Expression in HPB-ALL Cells. We have established a
series of cell populations that constitutively express the nef
gene ofHIV-1 (SF2 isolate; refs. 6 and 22). The human T-cell
line HPBALL/LnefSN-S1 was chosen to determine the
intracellular distribution of Nef because it is a human CD4+
T-cell line susceptible to HIV infection. As shown in Fig. 1,
HPBALL/LnefSN-S1 cells express a 27- to 29-kDa protein
that reacts specifically with a rabbit anti-Nef antiserum.
These cells were originally isolated by fluorescence-activated
cell sorting on the basis of their low CD4 cell surface levels
(22). A low level of surface CD4 expression correlates with
Nef expression and serves as an indicator of the presence of
a functional nefgene (22, 24).
Lcalization ofNefby Immunofluorescence. As a prelude to
the immunogold/electron microscopy studies to map the
subcellular localization of Nef, we performed immunofluo-
rescence studies with a polyclonal anti-Nef antiserum on
nef- (HPBALL/LN) and nef+ (HPBALL/LnefSN-Sl)
cells. As shown in Fig. 2, the cells are generally round and
contained a large kidney-shaped nucleus that filled most of
the volume ofthe cell. The cytoplasm was polar and was most
abundant near an indentation ofthe nucleus, typically seen in






FIG. 1. Specificity of anti-Nef rabbit
polyclonal antiserum. Extracts from HP-
BALL cells transduced with LnefSN or
a control vector, LN, were separated by
32.5 SDS/PAGE on 12.5% gels, and Nef was
detected by Western blot analysis with a
-.--Nef rabbit anti-Nef specific antiserum using=27.5 alkaline phosphatase-labeled goat anti-
rabbit antibodies (heavy chain specific)
as described in the text. The position of
Nef on the gel is indicated. Positions of
prestained molecular mass standards are
indicated in kDa.
homogeneous labeling of the cytoplasm (Fig. 2A). In general,
the distribution of Nef seems polar but this evidently is due
to the polar distribution of the cytoplasm; the thin ring of the
cytoplasm surrounding the nucleus, when visible, also
showed labeling. The nuclei, in general, showed little or no
fluorescence (Fig. 2A). However, focusing of the nuclei at
different planes revealed narrow bands of fluorescence in
some nuclei (Fig. 2B). These bands were seen in 8 of the 89
nuclei examined and each nucleus showed only one band.
The bands are very faint and required long exposures to
photograph them. No fluorescence was observed in nefr
cells incubated with the anti-Nef serum (Fig. 2C) or in nef+
cells incubated with normal rabbit serum (Fig. 2D), although
several hundred of these cells were examined.
Nuclear Localizaton ofNefby Immunogold Electron Micros-
copy. The technique used for immunogold labeling was the
post-embedding method (27). Fixed and dehydrated cells are
embedded in a water-soluble embedding resin (LR White) and
sectioned, and sections are incubated with primary and sec-
ondary (gold-conjugated) antibodies. We have maintained
three sets ofcontrols to ensure the specificity ofthe antibodies
used. First, we performed the immunogold labeling with
anti-Nef antibodies using sections of HPBALL/LN control
cells (nef-). As shown in Fig. 3A, the nonspecific binding of
the anti-Nef antibodies in these cells was negligible. Second,
as a control for nonspecific binding of primary and gold-
conjugated secondary antibodies, we performed immunogold
labeling on nef+ (HPBALL/LnefSN-S1) cells using normal
FIG. 2. Immunofluorescence analy-
sis of Nef+ (HPBALL/LnefSN-S1) and
Nef- (HPBALL/LN) cells with antise-
rum against Nef. (A) Nef+ cells labeled
with the anti-Nef antiserum show label in
the cytoplasm. (B) The NefW cells labeled
as inA were focused on the interior ofthe
nucleus. Note a fluorescent band across
the nucleus. (C) Nef- cells labeled with
the anti-Nef antiserum were not labeled.
(D) Nef+ cells labeled with normal rabbit
serum were also not labeled. (x800.)
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FIG. 3. Electron micrographs of controls for the immunogold
labeling technique. (A) Nef- cells were incubated with polyclonal
anti-Nef antiserum followed by gold-conjugated anti-rabbit antibody.
Labeling of cytoplasmic and nuclear components is negligible. (B)
Nef+ cells were incubated with normal rabbit antiserum followed by
goat anti-rabbit antibody conjugated with gold particles. No nonspe-
cifilc labeling of either cytoplasm or nucleus is evident. (C) Nef+ cells
were incubated with a monoclonal anti-intermediate filament (vi-
mentin) antibody followed by gold-conjugated (anti-mouse) second
antibodies. The label is seen over intermediate filaments (IF). M,
mitochondrion; C, centriole; N, nucleus; Cy, cytoplasm. (A, x8100;
B, x 8550; C, x 19,800.)
rabbit antiserum followed by gold-conjugated anti-rabbit an-
tibody. The results illustrated in Fig. 3B show that neither the
rabbit serum proteins nor the secondary antibodies bind
nonspecifically to nef+ cells. Finally, to check for the speci-
ficity of labeling of subcellular structures by immunogold
labeling method used here, nef+ cells were labeled with an
anti-vimentin (intermediate filament) specific antibody. The
intermediate filaments are readily identifiable cytoplasmic
structures that provide convenient markers to test the reso-
lution and specificity of immunogold labeling. The results
illustrated in Fig. 3C show the exclusive distribution of label
over the 10-nm intermediate filaments. Little or no labeling in
the nucleus was observed in any of these controls. These
studies suggest that the immunogold technique used here
provides specific labeling of subcellular structures.
When T cells expressing Nef (HPBALL/LnefSN-S1)
were examined by the immunogold labeling method, the
results were as follows. In a few sections of the nuclei the
label due to Nef was detected in highly localized tracks that
extended between the nuclear envelope and the nucleoplasm.
Fig. 4 illustrates these tracks in sections of three different
nuclei (A-C). The longest of the tracks measured about 7 Am
(Fig. 4A) and the tracks appeared to commence/terminate at
the cytoplasmic side of the nuclear envelope (Fig. 4B). The
tracks were seen in only 4 nuclei among 100 examined and
serial sections revealed only one track per nucleus. It is
possible that these tracks may occur with greater frequency
than that observed but that they are not detectable due to
technical reasons. The tracks occur in thin bands and occupy
a fraction of the total nuclear volume and, therefore, their
detection would depend on their perfect alignment to the
plane of sectioning. In addition to the tracks, a small amount
of label is also found in the nucleoplasm but the nucleoli are
totally free from the label. These tracks may correspond to
the fluorescence bands observed in a few nuclei by the
immunofluorescence method (Fig. 2B). A thorough exami-
nation of sections of hundreds of nuclei of nef- cells incu-
bated with anti-nef serum and nef+ cells incubated with
normal serum has failed to reveal any nuclear labeling. In fact
there is only one other instance in published literature
concerning a nuclear protein that forms tracks in the nucleus.
A study by Meier and Blobel (28) has shown that a nucleolar
phosphoprotein (Noppl40) of rat liver cells shuttles on tracks
that extend between the nucleolus and nuclear pore com-
plexes. The Nef tracks are different from Noppl40 tracks in
that they traverse the nucleoplasm with no relationship to the
nucleolus.
In the cytoplasm (data not shown) the label due to Nefwas
most abundant near the indentation of the nucleus as was the
case with cells processed by immunofluorescence (see Fig.
2A); this region contained most of the cell organelles, includ-
ing the microtubule organizing center, Golgi complex, and
vesicles.
Do the Nuclear Tracks Represent Cytoskeletal Filaments? It
has been hypothesized that the transport ofRNA (29, 30) and
proteins (28) occurs on specific tracks in the nucleus and that
these tracks may be composed of cytoskeletal filaments (e.g.,
microfilaments, microtubules, or intermediate filaments). To
determine if any of these filaments form tracks within the
nucleus of T cells, we have conducted immunogold labeling
studies with anti-tubulin, anti-vimentin, and anti-actin anti-
bodies. The nuclei remained largely unlabeled with either
anti-vimentin (Fig. 3C) or anti-tubulin antibodies (data not
shown). However, anti-actin antibodies showed some label-
ing of the nuclei (Fig. 5). Although not as clear as Nef tracks,
the label due to actin showed a preferential alignment in the
nucleus. Additionally, short tracks of actin were seen ex-
tending between the nuclear envelope and the nucleoplasm
(Fig. 5). These results are consistent with previous biochem-
ical evidence for the presence of actin in the nucleus (for
references, see ref. 28) and its proposed role in the shuttling
of proteins between the nucleus and cytoplasm (28).
DISCUSSION
The nefgene is present in HIV and SIV and several functions
have been ascribed to it. These functions include a negative
effect on HIV replication in vitro (31-34), down-regulation of
CD4 from the cell surface (8, 22, 24), and binding and
hydrolysis of GTP (35). Conflicting reports have also been
published questioning the role of Nef in each of the above
functions (9, 36). The issue of the biological function of Nef
is further complicated by the fact that isoforms of Nef exist
that differ either in the primary amino acid sequence or in
their posttranslational modification (37) and these isoforms
may have different functions.
In an attempt to gain insights into the function of Nef,
earlier studies have focused on the intracellular localization
of Nef using immunocytochemical studies at the light micro-
scopic level (7, 17-19, 21) and obtained varied results. Initial
studies suggested an exclusive cytoplasmic distribution of
Nef (7, 17), whereas three recent studies indicated the
presence of Nef in the nucleus as well (18, 19, 21). In the
present study our objective was to obtain a more precise
intracellular localization of Nef using immunogold labeling
techniques at the electron microscopic level.
The studies described here have important implications for
the function of Nef in HIV-1 life cycle and for the general
question ofthe import ofproteins into the nucleus. They have
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shown that a fraction ofNef is present in the nucleus and that
it occurs in localized tracks within the nucleoplasm. The
precise nuclear role of nuclear Nef remains unknown but
some previous studies have suggested a regulatory role for
Nef in the HIV gene expression (31-34). The localization of
Nef in distinct tracks in the nucleoplasm is significant in view
oftransport of proteins into the nucleus. The first example of
a nuclear protein that occurs in tracks is the nucleolar
FIG. 5. Electron micrograph showing immunogold labeling ofthe
nucleus of Nef+ cells with a monoclonal anti-actin antibody. In the
nucleus the actin label shows preferential alignment along tracks.
(Inset) Short track of actin label near the nuclear envelope (NE).
(x 27,000; Inset, x46,800.)
FIG. 4. Electron micrograph
showing immunogold labeling of
the nuclei of three different Nef+
cell.Noe te tracks of gold par-
~~. ~ ~ 5~E. tidles extending from the nuclear
pt, -Tf envelope to the nucleoplasm in A
s and B. (A) Arrows mark the track~~~ ~~~~ ~Of Nef label. (B) The tracks of Nef
~~~~ ~~~appear to originate in the cyto-
plasm (arrowhead). (C) Part of the
Nef track at high magnification.
NE, nuclear envelope; Cy, cyto-
plasm. (A, x23,800; B, x30,800;
C, x56,700.)
phosphoprotein (Noppl40) of rat liver cells (28). Noppl40
binds nuclear localization signal peptides and shuttles be-
tween the nucleolus and cytoplasm. Immunogold labeling
studies have shown that this protein occurs in tracks that
extend from the nuclear envelope to the fibrillar component
of the nucleolus. These results led the authors (28) to suggest
that Noppl40 shuttles on distinct tracks that may be com-
posed of actin with the motive force for transport being
generated by the putative nuclear myosin motors. Although
details of the mechanism of nuclear transport remain to be
resolved, it appears that most, if not all, macromolecular
traffic including that of mRNA molecules (29, 30) proceeds
on distinct nuclear pathways. To our knowledge, demonstra-
tion ofa nucleoplasmic protein on distinct tracks has not been
reported previously. The Nef tracks in the nucleus remark-
ably resemble the Noppl40 tracks and, like the latter, may
represent nuclear transport pathways. The fact that there is
only one Nef track per nucleus suggests that Nef traverses to
the nucleus along a single specific pathway into the nucleo-
plasm. As has been suggested before for Noppl40 (28), the
specificity may reside in the nuclear pore complex to which
the protein binds and to which the track is presumably
anchored.
Previous studies have shown that the eukaryotic nucleus
contains an organized matrix of proteinaceous filament that
provides a scaffold for the organization and function of the
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nuclear components (for references, see ref. 38). Recent
studies have shown that various biochemical reactions, in-
cluding DNA replication, transcription, and RNA process-
ing, take place on defined regions of the nuclear matrix and
the matrix may also provide tracks for the movement of
proteins and RNA transcripts (28-30) in and out of the
nucleus. The identity of proteins that compose the nuclear
matrix remains to be resolved. Some studies have implicated
lamins (proteins of the fibrous lamina beneath the inner
nuclear membrane) in forming the nuclear matrix (39); lamins
are related to proteins of cytoplasmic intermediate filaments
and can form coiled-coil rods, which, in turn, can associate
to form higher order structures (40). Another protein that has
been detected in the nucleus (for references, see ref. 28) and
is believed to compose the matrix is actin. It has also been
speculated that actin may provide tracks in the nucleus along
which macromolecules move in and out of the nucleus (28).
A recent study has demonstrated the affinity ofHIV-1 Nef to
the cytoskeletal components in vitro and in vivo (20). All of
these findings led us to conduct a preliminary immunogold
labeling study to determine if any of the major cytoskeletal
proteins occur in tracks within the nucleus. The results
suggested that, among the cytoskeletal proteins, actin ap-
pears to form short tracks within the nucleus.
The localization of Nef in the nucleus also led us to search
for a nuclear localization signal in the nef sequence. Since
Nef is found in the nucleoplasm and not in the nucleolus, we
focused on localization sequences on nucleoplasmic pro-
teins. Previous studies with Xenopus oocyte nuclear proteins
(nucleoplasmin and N1) have shown that these proteins share
a bipartite nuclear targeting motif (41). The motif consists of
a 16-amino acid sequence with two basic residues at the
amino-terminal end, 10 "spacer" residues, and a cluster of 4
basic residues at the carboxyl-terminal end (see below).
Amino acids in both basic domains are required for nuclear
targeting and the transport defect ofa mutation in one domain
is amplified by a simultaneous mutation in the other. In
addition to Xenopus proteins, a number of eukaryotic and
viral nuclear proteins contain this motif (41). The SF2 clone




The presence of the nuclear targeting sequence may be
required but not sufficient for the nuclear localization of Nef.
Indeed, a substantial fraction of Nef appears to be cytoplas-
mic associating with organelles and cytoskeletal elements,
suggesting that it may disrupt host cytoplasmic activities. It
is still possible that a fraction of Nef has a nuclear function
that is yet to be identified.
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